Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03242590 · FLOW

Participant flow

Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). · Source last updated 2019-10-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Oral testosterone undecanoate, LPCN 1021 225 mg TU two times a day. LPCN 1021: Oral testosterone undecanoate
    id
    FG000
    title
    Oral Testosterone Undecanoate, LPCN 1021
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        95
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        95
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Oral testosterone undecanoate, LPCN 1021 225 mg TU two times a day. LPCN 1021: Oral testosterone undecanoate
    id
    FG000
    title
    Oral Testosterone Undecanoate, LPCN 1021
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        95
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        95
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice